This interview features Nikolaj Sørensen, CEO of Orexo
Orexo is a specialty pharma company with commercial operations in the US and in Sweden developing improved treatments using proprietary drug-delivery technology. This video interview with Nikolaj Sørensen of Orexo covers:
- The company’s core technology competencies and focus on opioid addiction
- Orexo’s digital therapy for treatment of opioid addiction and the company’s growth strategy
- The benefits of trading in the US public markets on OTCQX
This content is provided by OTC Markets and did not involve IR Magazine journalists.
